Pharmaceutical Executive: February 2023

Clues on Equity Engagement Levels

February 09, 2023

Features

43

02

A survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.

Taking Steps to Right the Wrongs: The Impact of Racial Bias in Healthcare and Medicine

February 09, 2023

Features

43

02

Health disparities brought on by racial bias remain quite prevalent in areas such as drug access, use of diagnostics, and representation in clinical trials, but society-jarring events in recent years have sparked renewed efforts by industry to tackle these issues with tangible and hopeful gains.

Focus and Fundamentals: CFO Strategies on the Journey to Commercialization

February 09, 2023

Executive Roundtable

43

02

Chief financial officers and other finance experts discuss the continued market volatility impacting life sciences investment—and what biopharma companies can do to help accelerate its recovery. Quality science and “good data” still win the day.

Built for the Moment

February 09, 2023

Executive Profile

43

02

Starting out with limited pharma business knowledge, how the lessons learned and realizations made helped to forge a destined—and globe-spanning—leadership path for Christophe Bourdon, where today, as CEO of LEO Pharma, he is tasked with steering the longtime company’s return to profitability.